Topiramate and Valproate Compared in Treatment of Juvenile Myoclonic Epilepsy
A pilot, randomized, controlled trial comparing topiramate (n=19) and valproate (n=9) in adolescents/adults with juvenile myoclonic epilepsy (JME) was conducted in the Childrens Hospitals of Denver, CO, and Cincinnati, OH.
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2007-08-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/1003 |
Similar Items
-
Clinical features and treatment outcomes of Juvenile myoclonic epilepsy patients
by: Yingying Zhang, et al.
Published: (2019-06-01) -
Juvenile Myoclonic Epilepsy
by: J Gordon Millichap
Published: (1994-05-01) -
Carbamazepine-Induced Juvenile Myoclonic Seizures
by: J Gordon Millichap
Published: (2000-11-01) -
Prognosis of Benign Myoclonic Epilepsy of Infancy
by: J Gordon Millichap
Published: (2005-03-01) -
Long-Term Outcome of Juvenile Myoclonic Epilepsy
by: J Gordon Millichap
Published: (2014-01-01)